首页> 外文会议>Polymer reaction engineering X >BIOCOMPATIBLE SUPERPARAMAGNETIC POLY(THIOETHER-ESTER) NANOPARTICLES VIA MINIEMULSION TECHNIQUE
【24h】

BIOCOMPATIBLE SUPERPARAMAGNETIC POLY(THIOETHER-ESTER) NANOPARTICLES VIA MINIEMULSION TECHNIQUE

机译:通过微乳化技术实现生物相容的超顺磁性多(纳米级)脂肪族纳米粒子

获取原文
获取原文并翻译 | 示例

摘要

Biocompatible polymeric nanoparticles were obtained via thiol-ene polymerization of a biobased monomer in miniemulsion. The α.ω-diene-diester monomer was synthesized through esterification reaction of a glycerol derivative, namely 1,3-propanediol, with 10-undecenoic acid, a long-chain diene carboxylic acid. The biobased poly(thioether-ester), PTEE, nanoparticles were submitted to cytotoxicity and hemolysis analyses. High cell viability and no significant changes in cell morphology were observed. Lastly, hemolysis assays revealed blood compatibility and therefore PTEE nanoparticles have been shown to be a potential alternative drug delivery vector for intravenous administration. The poly(thioether-ester) was also employed to encapsulate magnetic nanoparticles (MNPs) by miniemulsification technique. MNPs were successfully incorporated in PTEE nanoparticles and VSM analysis showed that the resulting hybrid nanoparticles presented superparamagnetic behavior. According to the cell viability assays, MNPs-PTEE nanoparticles did not present any cytotoxic effect on HeLa cells. Fluorescence microscopy analysis demonstrated that the cellular uptake of MNPs-PTEE nanoparticles increased up to three times when an external magnetic field was applied. Therefore, the results indicated that the MNPs-PTEE nanoparticles can be an excellent alternative for the targeted delivery of antitumor drugs.
机译:通过在细乳液中生物基单体的硫醇-烯聚合获得生物相容性聚合物纳米颗粒。 α.ω-二烯-二酯单体是通过甘油衍生物即1,3-丙二醇与10-十一碳烯酸(一种长链二烯羧酸)的酯化反应合成的。生物基聚(硫醚酯),PTEE,纳米粒子被提交给细胞毒性和溶血分析。观察到细胞活力高,细胞形态无明显变化。最后,溶血测定法显示出血液相容性,因此已显示PTEE纳米粒子是用于静脉内给药的潜在替代药物递送载体。聚(硫醚酯)还用于通过微乳化技术包封磁性纳米颗粒(MNP)。 MNPs成功地掺入了PTEE纳米颗粒中,VSM分析表明所得的杂化纳米颗粒表现出超顺磁行为。根据细胞活力测定,MNPs-PTEE纳米颗粒对HeLa细胞没有任何细胞毒性作用。荧光显微镜分析表明,当施加外部磁场时,MNPs-PTEE纳米颗粒的细胞摄取增加了三倍。因此,结果表明,MNPs-PTEE纳米颗粒可以作为靶向递送抗肿瘤药物的绝佳替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号